The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,489–1,512 of 11,281
ArticlePsilocybin

Psilocybin modulates social behaviour in male and female mice in a time-dependent manner.

Shadani S, McCoy K, Ong L +4

Europe PMC2026
ArticlePsilocybin

Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.

Zhang T, Lin C, Wang X

Europe PMC2026
ArticleMDMA

Evaluation of illicit drug contaminants in seized cannabis in Arizona and California, 2023-2024.

Andersano B, Cahill TM, Grommes M +1

Europe PMC2026
ArticleKetamine

Neurodevelopmental and behavioral effects of early-life esketamine hydrochloride exposure in zebrafish (Danio rerio).

Zheng S, Du T, Wu K +1

Europe PMC2026
ArticlePsilocybin

Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.

Laursen DRT, Salazar J, Jürgens G +1

Europe PMC2026
ArticlePsychedelics

Psychedelics and neurostimulation for treatment resistant psychiatric disorders.

Blazek F, Latalova K, Krahulik D +1

Europe PMC2026
ArticlePsychedelics

Substance abuse and inflammation: consequences beyond the brain.

Yang L, Wheeler MA

Europe PMC2026
ArticleKetamine

Study protocol for the effect of intraoperative subanaesthetic dose esketamine on the incidence of postoperative depressive symptoms in patients with breast cancer: a multicentre, prospective, randomised controlled trial.

Li ZY, Wang J, Yang JS +7

Europe PMC2026
ArticleMDMA

From therapeutic promise to evidentiary discipline: Reassessing MDMA-assisted psychotherapy for posttraumatic stress disorder.

Suhardita K, Krisnanda VD, Saputra R +2

Europe PMC2026
PreprintPsilocybin

Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review

Bralic N, Bragagnolo E, Palner M

Europe PMC2026
ArticleKetamine

Ketamine-based ICU sedation and patient-centered outcomes: A systematic review and meta-analysis of mechanical ventilation duration, ICU length of stay, and delirium.

Patel R, Thompson J, Elsayed B +3

Europe PMC2026
ArticlePsychedelics

Emerging therapeutic opportunities for psychedelic and related drugs.

Wonnacott S, Stephens GJ, Sharp T

Europe PMC2026
ArticleDMT

Speech markers of psychological change following a psychedelic 5-MeO-DMT retreat.

Kuc J, McAlpine RG, Sellers A +3

Europe PMC2026
ArticleKetamine

Efficacy and Safety of Esketamine in Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

AlAyyaf AE, Alharran AM, Al-Mutairi M +6

Europe PMC2026
TrialPsilocybin

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

ClinicalTrials.gov2026
ProjectPsilocybin

Psilocybin for Anxiety

OSF2026
ArticleIbogaine

Exploring the Use of Ibogaine in Opioid Recovery: Insights from Lived Experience.

Walker J, Deering D, Unger BH

Europe PMC2026
TrialMDMA

MDMA Assisted Therapy for BN

ClinicalTrials.gov2026
ArticleKetamine

Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression.

Patarroyo-Rodriguez L, Pazdernik VK, Vande Voort JL +2

Europe PMC2026
ArticlePsychedelics

Intention-Setting Among Recreational Psychedelic Users: Associated Acute Effects and Changes in Well-Being.

Low F, Earleywine M

Europe PMC2026
ProjectPsychedelics

Psychedelics in the Probabilistic Reversal Learning Task

OSF2026
ArticleMescaline

Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.

Cavallaro N, Rai P, Akins D +9

Europe PMC2026
ArticleLSD

Lysergic acid diethylamide pretreatment prolongs brain-stimulation induced neural activity changes.

Dwiel LL, Prina ML, Bragg EM +5

Europe PMC2026
ArticleMDMA

Differential alterations in peripheral tryptophan pathways in methamphetamine versus MDMA users are linked to their contrasting psychiatric symptoms.

Bavato F, Steuer A, Jacobsen AM +8

Europe PMC2026